214 related articles for article (PubMed ID: 35196980)
1. Identifying pathways regulating the oncogenic p53 family member ΔNp63 provides therapeutic avenues for squamous cell carcinoma.
Pokorna Z; Vyslouzil J; Vojtesek B; Coates PJ
Cell Mol Biol Lett; 2022 Feb; 27(1):18. PubMed ID: 35196980
[TBL] [Abstract][Full Text] [Related]
2. ΔNp63 activates the Fanconi anemia DNA repair pathway and limits the efficacy of cisplatin treatment in squamous cell carcinoma.
Bretz AC; Gittler MP; Charles JP; Gremke N; Eckhardt I; Mernberger M; Mandic R; Thomale J; Nist A; Wanzel M; Stiewe T
Nucleic Acids Res; 2016 Apr; 44(7):3204-18. PubMed ID: 26819410
[TBL] [Abstract][Full Text] [Related]
3. Physical association of HDAC1 and HDAC2 with p63 mediates transcriptional repression and tumor maintenance in squamous cell carcinoma.
Ramsey MR; He L; Forster N; Ory B; Ellisen LW
Cancer Res; 2011 Jul; 71(13):4373-9. PubMed ID: 21527555
[TBL] [Abstract][Full Text] [Related]
4. DeltaNp63, a target of DEC1 and histone deacetylase 2, modulates the efficacy of histone deacetylase inhibitors in growth suppression and keratinocyte differentiation.
Qian Y; Jung YS; Chen X
J Biol Chem; 2011 Apr; 286(14):12033-41. PubMed ID: 21317427
[TBL] [Abstract][Full Text] [Related]
5. DNA Demethylation Switches Oncogenic ΔNp63 to Tumor Suppressive TAp63 in Squamous Cell Carcinoma.
Pokorna Z; Hrabal V; Tichy V; Vojtesek B; Coates PJ
Front Oncol; 2022; 12():924354. PubMed ID: 35912167
[TBL] [Abstract][Full Text] [Related]
6. Ras and TGF-β signaling enhance cancer progression by promoting the ΔNp63 transcriptional program.
Vasilaki E; Morikawa M; Koinuma D; Mizutani A; Hirano Y; Ehata S; Sundqvist A; Kawasaki N; Cedervall J; Olsson AK; Aburatani H; Moustakas A; Miyazono K; Heldin CH
Sci Signal; 2016 Aug; 9(442):ra84. PubMed ID: 27555661
[TBL] [Abstract][Full Text] [Related]
7. Induction of ΔNp63 by the newly identified keratinocyte-specific transforming growth factor β Signaling Pathway with Smad2 and IκB Kinase α in squamous cell carcinoma.
Fukunishi N; Katoh I; Tomimori Y; Tsukinoki K; Hata R; Nakao A; Ikawa Y; Kurata S
Neoplasia; 2010 Dec; 12(12):969-79. PubMed ID: 21170261
[TBL] [Abstract][Full Text] [Related]
8. TP63 P2 promoter functional analysis identifies β-catenin as a key regulator of ΔNp63 expression.
Ruptier C; De Gaspéris A; Ansieau S; Granjon A; Tanière P; Lafosse I; Shi H; Petitjean A; Taranchon-Clermont E; Tribollet V; Voeltzel T; Scoazec JY; Maguer-Satta V; Puisieux A; Hainaut P; Cavard C; Caron de Fromentel C
Oncogene; 2011 Nov; 30(46):4656-65. PubMed ID: 21643019
[TBL] [Abstract][Full Text] [Related]
9. ΔNp63/DGCR8-Dependent MicroRNAs Mediate Therapeutic Efficacy of HDAC Inhibitors in Cancer.
Napoli M; Venkatanarayan A; Raulji P; Meyers BA; Norton W; Mangala LS; Sood AK; Rodriguez-Aguayo C; Lopez-Berestein G; Vin H; Duvic M; Tetzlaff MB; Curry JL; Rook AH; Abbas HA; Coarfa C; Gunaratne PH; Tsai KY; Flores ER
Cancer Cell; 2016 Jun; 29(6):874-888. PubMed ID: 27300436
[TBL] [Abstract][Full Text] [Related]
10. Complex and variable regulation of ΔNp63 and TAp63 by TGFβ has implications for the dynamics of squamous cell epithelial to mesenchymal transition.
Pokorná Z; Tylichová Z; Vojtesek B; Coates PJ
Sci Rep; 2024 Mar; 14(1):7304. PubMed ID: 38538801
[TBL] [Abstract][Full Text] [Related]
11. ΔNp63 in squamous cell carcinoma: defining the oncogenic routes affecting epigenetic landscape and tumour microenvironment.
Gatti V; Fierro C; Annicchiarico-Petruzzelli M; Melino G; Peschiaroli A
Mol Oncol; 2019 May; 13(5):981-1001. PubMed ID: 30845357
[TBL] [Abstract][Full Text] [Related]
12. ΔNp63 promotes IGF1 signalling through IRS1 in squamous cell carcinoma.
Frezza V; Fierro C; Gatti E; Peschiaroli A; Lena AM; Petruzzelli MA; Candi E; Anemona L; Mauriello A; Pelicci PG; Melino G; Bernassola F
Aging (Albany NY); 2018 Dec; 10(12):4224-4240. PubMed ID: 30594912
[TBL] [Abstract][Full Text] [Related]
13. ΔNp63-mediated regulation of hyaluronic acid metabolism and signaling supports HNSCC tumorigenesis.
Compagnone M; Gatti V; Presutti D; Ruberti G; Fierro C; Markert EK; Vousden KH; Zhou H; Mauriello A; Anemone L; Bongiorno-Borbone L; Melino G; Peschiaroli A
Proc Natl Acad Sci U S A; 2017 Dec; 114(50):13254-13259. PubMed ID: 29162693
[TBL] [Abstract][Full Text] [Related]
14. p63 regulates growth of esophageal squamous carcinoma cells via the Akt signaling pathway.
Ye S; Lee KB; Park MH; Lee JS; Kim SM
Int J Oncol; 2014 Jun; 44(6):2153-9. PubMed ID: 24718831
[TBL] [Abstract][Full Text] [Related]
15. STXBP4 regulates APC/C-mediated p63 turnover and drives squamous cell carcinogenesis.
Rokudai S; Li Y; Otaka Y; Fujieda M; Owens DM; Christiano AM; Nishiyama M; Prives C
Proc Natl Acad Sci U S A; 2018 May; 115(21):E4806-E4814. PubMed ID: 29735662
[TBL] [Abstract][Full Text] [Related]
16. Regulation of p63 isoforms by snail and slug transcription factors in human squamous cell carcinoma.
Herfs M; Hubert P; Suarez-Carmona M; Reschner A; Saussez S; Berx G; Savagner P; Boniver J; Delvenne P
Am J Pathol; 2010 Apr; 176(4):1941-9. PubMed ID: 20150431
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol-induced p53-independent apoptosis of human nasopharyngeal carcinoma cells is correlated with the downregulation of ΔNp63.
Chow SE; Wang JS; Chuang SF; Chang YL; Chu WK; Chen WS; Chen YW
Cancer Gene Ther; 2010 Dec; 17(12):872-82. PubMed ID: 20725098
[TBL] [Abstract][Full Text] [Related]
18. Family matters: sibling rivalry and bonding between p53 and p63 in cancer.
Romano RA; Sinha S
Exp Dermatol; 2014 Apr; 23(4):238-9. PubMed ID: 24690037
[TBL] [Abstract][Full Text] [Related]
19. ΔNp63 isoform-mediated β-defensin family up-regulation is associated with (lymph)angiogenesis and poor prognosis in patients with squamous cell carcinoma.
Suarez-Carmona M; Hubert P; Gonzalez A; Duray A; Roncarati P; Erpicum C; Boniver J; Castronovo V; Noel A; Saussez S; Peulen O; Delvenne P; Herfs M
Oncotarget; 2014 Apr; 5(7):1856-68. PubMed ID: 24732135
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.
Kakuki T; Kurose M; Takano K; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Takahashi S; Hatakeyama T; Kohno T; Himi T; Kojima T
Oncotarget; 2016 Jun; 7(23):33887-900. PubMed ID: 27036044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
